Optimization of Human Mesenchymal Stem Cells for Rheumatoid Arthritis: Implications for Improved Therapeutic Outcomes

OBJECTIVE: Seropositive rheumatoid arthritis (RA) is a chronic autoimmune disease that is rarely “cured.” Human mesenchymal stem cells (hMSCs) are known to reduce inflammation and restore immune homeostasis. However, methods for predicting therapeutic hMSC potency have not been established. The goal...

Descripción completa

Detalles Bibliográficos
Autores principales: Breitman, Maya, Bonfield, Tracey L., Caplan, Arnold I., Lazarus, Hillard M., Haghiac, Maricela, LaSalvia, Susan, Reese‐Koc, Jane, Singer, Nora G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Periodicals, Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843759/
https://www.ncbi.nlm.nih.gov/pubmed/34792869
http://dx.doi.org/10.1002/acr2.11356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8843759/
https://www.ncbi.nlm.nih.gov/pubmed/34792869
http://dx.doi.org/10.1002/acr2.11356

Ejemplares similares